Edward Hendron serves as a Senior Recruiter at Iovance Biotherapeutics, Inc., where he plays a pivotal role in shaping the company's talent acquisition strategy in the rapidly evolving field of immunotherapy. With 24 years of extensive experience in sourcing, recruiting, and retaining top-tier talent, Edward...
Edward Hendron serves as a Senior Recruiter at Iovance Biotherapeutics, Inc., where he plays a pivotal role in shaping the company's talent acquisition strategy in the rapidly evolving field of immunotherapy. With 24 years of extensive experience in sourcing, recruiting, and retaining top-tier talent, Edward is instrumental in building a diverse and inclusive workforce that aligns with Iovance's mission to innovate and deliver groundbreaking tumor infiltrating lymphocyte (TIL) therapy for cancer patients. His expertise in inclusion and diversity recruitment not only enhances the company’s employer branding but also fosters a culture of belonging that is essential for driving innovation in healthcare.
At Iovance, Edward leads key projects that focus on enhancing recruitment processes, optimizing vendor management, and implementing strategic college recruiting initiatives. His servant leadership style empowers sourcing and recruiting teams to excel in identifying candidates who possess both the technical skills and the passion necessary to contribute to the company's transformative approach to cancer treatment. Edward's proven track record in executive recruitment and career management ensures that Iovance attracts and retains professionals who are not only experts in their fields but also aligned with the organization’s values and vision.
In a landscape where healthcare IT and advanced therapeutic solutions are paramount, Edward’s ability to build strong relationships with candidates and hiring managers alike is a critical asset. His dedication to career opportunities and training further solidifies Iovance's position as a leader in the biotherapeutics industry, ultimately contributing to the advancement of life-saving therapies for patients battling cancer.
